ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2016
[Analysis of Pathological Types and Clinical Epidemiology of 6,058 Patients with Lung Cancer].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Sex-divergent anatomic system concordance in second primary malignant neoplasms: a large-scale analysis.Frontiers in oncology · 2025Article
- [Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024Article
- The mediating role of self-efficacy in the relationship between social support and work withdrawal behavior: A cross-sectional study among young lung cancer survivors.Asia-Pacific journal of oncology nursing · 2023Article
- A Simple Method to Train the AI Diagnosis Model of Pulmonary Nodules.Computational and mathematical methods in medicine · 2020Article
- Epidemiology of lung cancer in northeast of Iran: A 25-year study of 939 patients.Medical journal of the Islamic Republic of Iran · 2020Article
- [Cyclic RNA Molecule circ_0007766 Promotes the Proliferation of Lung Adenocarcinoma Cells by Up-regulating the Expression of Cyclin D1/CyclinE1/CDK4].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019Article
- [Establishment and Verification of A Novel Predictive Model of Malignancy for Non-solid Pulmonary Nodules].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019Article
- [Prognostic Value of Neutrophil-to-lymphocyte Ratio in Patients with Lung Adenocarcinoma Treated with Radical Dissection].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018Article
- Observational
- Analysis of risk factors for stage I lung adenocarcinoma using low-dose high-resolution computed tomography.Oncology letters · 2018Article
- [A Retrospective Study of Mean Computed Tomography Value to Predict the Tumor Invasiveness in AAH and Clinical Stage Ia Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018Article
- Effect of early palliative care on quality of life in patients with non-small-cell lung cancer.Current oncology (Toronto, Ont.) · 2018Article
- [Clinical and Prognosic Anylasis of 30 Cases with Double Primary Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
- [Impact of Lung Cancer Deaths on Life Expectancy and Years of Potential Life Lost from 1981 to 2015 in Kunshan, Jiangsu Province, China].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveThe epidemiology of lung cancer changes with time, region, and population. The pathological and clinical characteristics of patients with primary bronchial lung cancer were retrospectively analyzed to understand the epidemic trend of lung cancer in recent years.
methodsWe reviewed the clinical data of patients with primary bronchogenic carcinoma. These patients, who are permanent residents of Henan province, were treated in the First Affiliated Hospital of Zhengzhou University from 2012 to 2014. The distributions of gender, age, urban/rural residency, smoking history, drinking history, operation history, and histological types of tumor were compared among the patients and analyzed.
resultsA total of 6,058 cases of lung cancer were collected, including 1,495 cases in 2012, 2,070 cases in 2013 and 2,493 cases in 2014. The proportions of male to female patients with lung cancer were 2.26:1, 2.29:1 and 2.20:1 in 2012 to 2014, respectively (χ²=0.367, P=0.832). The age of onset was 60-69 years old, which accounted for 35.72% of the patients, and exhibited statistically significant differences between male and female patients (χ²=109.848, P<0.001). Moreover, differences in the pathological types of patients with lung cancer were statistically significant in 2012-2014 (χ²=25.344, P=0.013). Lung adenocarcinoma accounted for 38.5% and 73.63% in male and female patients, respectively, and the difference was statistically significant (χ²=562.382, P<0.001). Adenocarcinoma also accounted for 60.62%, 56.59%, 49.84%, 45.15%, 47.03% and 41.25% in all ages of patients with lung cancer; the difference was statistically significant (χ²=48.886, P<0.001). Furthermore, the proportions of various pathological types in rural and urban patients were statistically significant among the five regions of Henan Province. The proportions of squamous cell carcinoma were the highest in smoking and drinking patients, accounting for 38.39% and 37.37%, respectively. About 15.4% of the patients included in the study received surgical treatment.
conclusionsThe proportion of adenocarcinoma in all types of lung cancer has increased in recent years, whereas the incidence of squamous cell carcinoma has declined. Adenocarcinoma is common in male patients with lung cancer as well as in young- and middle-aged patients. Squamous cell carcinoma is associated with smoking and drinking in male patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.